Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- 1 January 2021
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of Sport Medicine
- Vol. 28 (1), E150-E156
- https://doi.org/10.1097/MJT.0000000000001002
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO studyAnnals Of Oncology, 2007
- Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-AnalysisJNCI Journal of the National Cancer Institute, 2005
- Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survivalAnnals of Oncology, 2005
- Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO‐94Colorectal Disease, 2003
- Résultats à 10 ans d'un essai randomisé de chimiothérapie néo-adjuvante dans les cancers du sein de plus de 3 cmChirurgie, 1998
- P78 Primary chemotherapy in conservative treatment of stage II breast cancer patientsEuropean Journal Of Cancer, 1998
- P73 Neoadjuvant therapy in stage II with T≥4CM and stage III breast cancerEuropean Journal Of Cancer, 1998
- Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancerBritish Journal of Surgery, 1995
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Neoadjuvant chemotherapy in operable breast cancerEuropean Journal of Cancer and Clinical Oncology, 1991